Skip to main content
Premium Trial:

Request an Annual Quote

PROTEOMICS COMPUTING Compaq to put infrastructure in structural genomix

Premium

When Structural GenomiX decided to buy $2 million to $3 million worth of equipment from Compaq, the computer company’s reputation for its previous deals had a big role. “If you judge companies by the company they keep,” says SGX CEO Tim Harris, “I don’t mind being with Celera and GeneProt.”

In addition to the equipment deal, SGX will also explore a longer-term strategic relationship. “We are committed to an initial purchase and an ongoing partnership with Compaq,” says Tod Klingler, vice president of information sciences at SGX.

The deal provides SGX’s protein-structure prediction operation with Compaq’s Alpha chips. Klingler says he chose Alphas for their speed with protein-prediction algorithms.

During the next year, Compaq will supply SGX with a 1,200-CPU Alpha compute farm running Tru64 Unix and a 100-node Linux/Intel compute farm, says Daniel Joy, business development manager for Compaq’s life sciences group.

Compaq may take an equity stake in SGX, hints Lionel Binns, worldwide life and materials sciences group manager for high-performance technical computing at Compaq. Indeed, his company’s relationship with GeneProt included such a provision.

“Structural GenomiX is the clear leader in modeling proteins for commercial use,” Binns says. “Our strategy is to always look for the emerging leader in any particular area [as] it buys us market presence, credibility, and influence.”

— Ken Howard

 

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.